Halt Medical Inc.
http://acessa.tower61.com/
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Halt Medical Inc.
Device/Diagnostics Quarterly Deal-Making Statistics, Q2 2017
Device and diagnostics fundraising slumped in Q2, but there was a substantial uptick in M&A activity. Device financings totaled just slightly over half of the previous quarter, while acquisitions grew almost six-fold, thanks primarily to Becton Dickinson's $23.5 billion play for CR Bard. Financing in diagnostics slid to $1.03 billion, less than half of Q1, whereas the $1.7 billion in M&As (most of that from PerkinElmer's $1.3 billion buy of EuroImmun) was more than double Q1's aggregate.
Medtech Execs On The Move, April 2016
Recent executive-level company changes and promotions in the medical device and diagnostics industries.
Start-Up Execs On The Move, April 2016
Recent executive-level hires and director appointments at venture capital firms and biopharma and medtech start-ups.
Execs On The Move, April 2016
Recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.
Company Information
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice